The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Palmitylcarnitine     (3S)-3-hexadecanoyloxy-4- trimethylammonio...

Synonyms: CPD-419, CHEMBL2216787, CHEBI:17490, LS-17082, LS-17083, ...
This record was replaced with 16903.
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of [(2S)-3-carboxy-2-hexadecanoyloxy-propyl]-trimethyl-azanium

 

High impact information on [(2S)-3-carboxy-2-hexadecanoyloxy-propyl]-trimethyl-azanium

 

Biological context of [(2S)-3-carboxy-2-hexadecanoyloxy-propyl]-trimethyl-azanium

 

Anatomical context of [(2S)-3-carboxy-2-hexadecanoyloxy-propyl]-trimethyl-azanium

 

Associations of [(2S)-3-carboxy-2-hexadecanoyloxy-propyl]-trimethyl-azanium with other chemical compounds

 

Gene context of [(2S)-3-carboxy-2-hexadecanoyloxy-propyl]-trimethyl-azanium

 

Analytical, diagnostic and therapeutic context of [(2S)-3-carboxy-2-hexadecanoyloxy-propyl]-trimethyl-azanium

References

  1. Palmitoyl-L-carnitine increases the release of prostacyclin from vascular endothelial cells. Boeynaems, J.M., Ramboer, I., Pirotton, S. Biochem. Pharmacol. (1989) [Pubmed]
  2. Palmitoyl-L-carnitine modifies the myocardial levels of high-energy phosphates and free fatty acids. Xiao, C.Y., Chen, M., Hara, A., Hashizume, H., Abiko, Y. Basic Res. Cardiol. (1997) [Pubmed]
  3. Hepatic mitochondrial function in ketogenic states. Diabetes, starvation, and after growth hormone administration. DiMarco, J.P., Hoppel, C. J. Clin. Invest. (1975) [Pubmed]
  4. Changes of hepatic fatty acid metabolism produced by chronic thioacetamide administration in rats. Nozu, F., Takeyama, N., Tanaka, T. Hepatology (1992) [Pubmed]
  5. Involvement of protein kinase C in the regulation of ornithine decarboxylase mRNA by phorbol esters in rat hepatoma cells. Butler, A.P., Mar, P.K., McDonald, F.F., Ramsay, R.L. Exp. Cell Res. (1991) [Pubmed]
  6. OCTN3: A Na+-independent L-carnitine transporter in enterocytes basolateral membrane. Durán, J.M., Peral, M.J., Calonge, M.L., Ilundáin, A.A. J. Cell. Physiol. (2005) [Pubmed]
  7. Palmitoyl-L-carnitine modifies the function of vascular endothelium. Inoue, N., Hirata, K., Akita, H., Yokoyama, M. Cardiovasc. Res. (1994) [Pubmed]
  8. Different subcellular localization of palmitoyl-L-carnitine hydrolysis in human and rat liver. Hagen, L.E., Berge, R.K., Farstad, M. FEBS Lett. (1979) [Pubmed]
  9. Beneficial effects of dilazep on the palmitoyl-L-carnitine-induced derangements in isolated, perfused rat heart: comparison with tetrodotoxin. Hara, A., Arakawa, J., Hashizume, H., Abiko, Y. Jpn. J. Pharmacol. (1997) [Pubmed]
  10. Effect of fatty acids and ketones on the activity of pyruvate dehydrogenase in skeletal-muscle mitochondria. Ashour, B., Hansford, R.G. Biochem. J. (1983) [Pubmed]
  11. Relationships between the effects of superoxide anion and palmitoyl-L-carnitine on the Ca(2+)-ATPase of vascular smooth muscle sarcoplasmic reticulum. Suzuki, Y.J., Packer, L., Ford, G.D. J. Mol. Cell. Cardiol. (1993) [Pubmed]
  12. Effects of 2-mercaptoacetate in isolated liver mitochondria in vitro. Competitive inhibition of 3-hydroxybutyrate dehydrogenase and depression of the beta-oxidation pathway. Bauché, F., Sabourault, D., Giudicelli, Y., Nordmann, J., Nordmann, R. Biochem. J. (1982) [Pubmed]
  13. Hepatic and cardiac carnitine palmitoyltransferase activity. Effects of adriamycin and galactosamine. Brady, L.J., Brady, P.S. Biochem. Pharmacol. (1987) [Pubmed]
  14. Functional characterization of intestinal L-carnitine transport. Durán, J.M., Peral, M.J., Calonge, M.L., Ilundáin, A.A. J. Membr. Biol. (2002) [Pubmed]
  15. Does growth hormone treatment alter skeletal muscle mitochondrial respiration in rats? Peyreigne, C., Raynaud, E., Fedou, C., Prefaut, C., Brun, J.F., Mercier, J. Horm. Res. (2002) [Pubmed]
  16. 3-Thia fatty acid treatment, in contrast to eicosapentaenoic acid and starvation, induces gene expression of carnitine palmitoyltransferase-II in rat liver. Madsen, L., Berge, R.K. Lipids (1999) [Pubmed]
  17. Inhibition of biological actions of 12-O-tetradecanoylphorbol-13-acetate by inhibitors of protein kinase C. Tanaka, K., Ono, T., Umeda, M. Jpn. J. Cancer Res. (1986) [Pubmed]
  18. Effect of L-carnitine and palmitoyl-L-carnitine on erythroid colony formation in fetal mouse liver cell culture. Matsumura, M., Hatakeyama, S., Koni, I., Mabuchi, H. American journal of nephrology. (1998) [Pubmed]
  19. Skeletal muscle mitochondrial ATP production rate and walking performance in peripheral arterial disease. Hou, X.Y., Green, S., Askew, C.D., Barker, G., Green, A., Walker, P.J. Clinical physiology and functional imaging. (2002) [Pubmed]
  20. Mitochondrial oxidative metabolism during respiratory infection in riboflavin deficient mice. Brijlal, S., Lakshmi, A.V., Bamji, M.S. J. Nutr. Biochem. (1999) [Pubmed]
 
WikiGenes - Universities